Table 1.

Demographic characteristics of 153 patients followed after participation in WGET.

Characteristic	Etanercept (E) (n=77)	Placebo (P) (n=76)	Total (n=153)	E versus P p value
Gender, male, n (%)	50 (65%)	44(58%)	94 (61%)	0.37
Age
enrollment, mean (SD)	52 (14)	49 (17)	50 (15)	0.15
last contact, mean (SD)	57 (14)	54 (17)	55 (15)	0.14
Race n (%)
White, non-Hispanic	69 (90%)	72 (95%)	141 (92%)	0.4
Black, non-Hispanic	2 (2.5%)	0 (0%)	2 (1%)	0.5
Hispanic	4 (5%)	2 (2.5%)	6 (4%)	0.4
Other	2 (2.5%)	2 (2.5%)	4 (3%)	0.2
Vital status, alive, (%)	65 (84%)	66 (87 %)	131 (86%)	0.7
Previous history of cancer, n(%)	12 (16%)	5 (7%)	17 (11%)	0.7
Family history of cancer, n(%)	15 (19%)	14 (18%)	29 (19%)	0.9
Tobacco use
Current use, no (%)	1 (1%)	1 (1%)	2 (1%)	0.99
Previous use, no (%)	22 (29%)	10 (13%)	32 (21%)	0.015